Showing 7,821 - 7,840 results of 20,793 for search '"Therapy"', query time: 0.13s Refine Results
  1. 7821

    Enterococcus Faecalis Endocarditis Following Percutaneous Manipulation of a Biliary Tract Calculus and ERCP by Allan R Ronald, Andrew LS Pattullo

    Published 1990-01-01
    “…Cure was obtained when therapy with ampicillin and gentamicin was undertaken.…”
    Get full text
    Article
  2. 7822
  3. 7823

    Hyperuricemia, use of antituberculosis drugs, and liver injury: case report by Vina Yuwantari, Nur Oktafiyani, Nurmelinda Hadi Ningrum, M. Hari Pristantiningtyas, Herya Putra Dharma, Muhammad Muchlis, Jainuri Erik Pratama, Fauna Herawati, Adji Prayitno Setiadi, Marisca Evalina Gondokesumo

    Published 2023-08-01
    “…The patient's condition improved after this modification of therapy so that therapy with three anti-TB drugs was continued until he was discharged from the hospital.…”
    Get full text
    Article
  4. 7824

    Perbedan Terapi Madu dan Multi Vitamin Terhadap Kadar Hemoglobin, Albumin dan Status Nutrisi Pada Anak Balita by Meri Neherta

    Published 2011-12-01
    “…The sample size is 60 toddlers, where 30 toddlers received multivitamin therapy, and 30 others received honey therapy for 30 days. …”
    Get full text
    Article
  5. 7825

    Impact of Pentoxifylline and Vitamin E on Ribavirin-Induced Haemolytic Anaemia in Chronic Hepatitis C Patients: An Egyptian Survey by M. Assem, M. Yousri

    Published 2011-01-01
    “…Selected 200 naïve chronic HCV patients, were randomized to receive either the standard antiviral therapy (peginterferon α-2b and RBV) plus pentoxifylline (800 mg) and high-dose vitamin E (1000 iu) daily (combined group) or received standard antiviral therapy plus placebo only (control group). …”
    Get full text
    Article
  6. 7826

    Rehabilitation exercise for treatment of vestibular disorder: A case study by Avraham Feazadeh, Eli Carmeli

    Published 2006-01-01
    “…Four weeks from the start of physical therapy, the patient was free of symptoms, even when her neck was in the extended position.…”
    Get full text
    Article
  7. 7827

    Recurrent Catatonia due to Episodic Obsessive-Compulsive Disorder by Soumitra Das, Sakshi Prasad, Palak Atul Fichadia, Abhigan Babu Shrestha, Ozge C. Amuk Williams, Anil Bachu

    Published 2022-01-01
    “…She was also educated about OCD through a series of therapy sessions and exposure and response prevention (ERP) principles. …”
    Get full text
    Article
  8. 7828

    Acute Acalculous Cholecystitis: A Rare Presentation of Primary Epstein-Barr Virus Infection in Adults—Case Report and Review of the Literature by Zuhal Yesilbag, Asli Karadeniz, Fatih Oner Kaya

    Published 2017-01-01
    “…Only one patient underwent surgery and all other patients recovered with conservative therapy. The development of AAC should be kept in mind in patients with cholestatic hepatitis due to EBV infection to avoid unnecessary surgical therapy and overuse of antibiotics.…”
    Get full text
    Article
  9. 7829

    Predictive Factors in OCT Analysis for Visual Outcome in Exudative AMD by Maria-Andreea Gamulescu, Georgios Panagakis, Carmen Theek, Horst Helbig

    Published 2012-01-01
    “…Reliable predictive factors for therapy outcome may enable treating physicians to counsel their patients more efficiently concerning probability of improvement or time point of discontinuation of a certain therapy. …”
    Get full text
    Article
  10. 7830

    Splenic Abscess: An Uncommon Entity with Potentially Life-Threatening Evolution by Mei-Chun Lee, Chun-Ming Lee

    Published 2018-01-01
    “…Patients with splenic abscesses receiving antimicrobial therapy alone were in a relatively high proportion and got a good prognosis especially in patients with small and multiple abscesses.…”
    Get full text
    Article
  11. 7831

    Aspirin does not confer protection against major ischemic vascular events in patients diagnosed with rheumatoid arthritis by Chao Gao, Qiqi Hou, Hongxia Cao, Cangtuo Li, Xu Peng, Quanle Han, Shouling Wu, Kangbo Li

    Published 2025-02-01
    “…The relationship between ASA therapy and major ischemic vascular events was analyzed by Cox proportional hazards regression. …”
    Get full text
    Article
  12. 7832

    Interferon-gamma: A Potent Antiviral Agent Targeting Macrophages Infected with LP-BM5 Murine Leukemia Virus, the Causative Agent of 'AIDS' in Mice by Jens J Kort, Julie L Eiseman

    Published 1992-01-01
    “…Further, since a lower concentration of each agent was required for efficacy in combination therapy, toxicity associated with single agent therapy may be avoided.…”
    Get full text
    Article
  13. 7833

    Vaccines and Immunotherapeutics for the Treatment of Malignant Disease by Joel F. Aldrich, Devin B. Lowe, Michael H. Shearer, Richard E. Winn, Cynthia A. Jumper, Ronald C. Kennedy

    Published 2010-01-01
    “…A number of immunotherapeutic strategies have arisen for the treatment of malignant disease, including various vaccination schemes, cytokine therapy, adoptive cellular therapy, and monoclonal antibody therapy. …”
    Get full text
    Article
  14. 7834

    Prospects of MMX Mesalazine in Routine Outpatient Treatment of Ulcerative Colitis by Yu. P. Uspenskiy, S. V. Ivanov, Yu. A. Fominykh

    Published 2022-03-01
    “…The 5-ASA therapy remains the mainstay UC treatment in routine outpatient practice, with prescription rate of 80–90%. …”
    Get full text
    Article
  15. 7835

    Rimegepant for the treatment of migraine by Amnon A. Berger, Ariel Winnick, Austin H. Carroll, Alexandra Welschmeyer, Nathan Li, Marc Colon, Antonella Paladini, Giovanni F. Ramírez, Jamal Hasoon, Elyse M. Cornett, Jaehong Song, Giustino Varrassi, Adam M. Kaye, Alan D. Kaye, Latha Ganti

    Published 2022-10-01
    “…Prophylactic therapy may reduce the occurrence of acute migraine attacks in selected patients, but does not completely eliminate it. …”
    Get full text
    Article
  16. 7836

    Effect of Oral PUVAsol on the Quality of Life in Indian Patients Having Chronic Plaque Psoriasis by Pratik Gahalaut, Nitin Mishra, Puneet S. Soodan, Madhur K. Rastogi

    Published 2014-01-01
    “…PUVAsol has been successfully used for treating psoriasis instead of standard PUVA therapy in developing countries. However, data for PUVAsol therapy and its effect on QoL in psoriatic patients is meagre. …”
    Get full text
    Article
  17. 7837

    Current landscape and future prospects of interleukin-2 receptor (IL-2R) agonists in cancer immunotherapy by Kengo Tanigawa, William L. Redmond

    Published 2025-12-01
    “…This review will explore IL-2 biology, the clinical application of HD IL-2 therapy, and the development of novel IL-2 R agonists for cancer immunotherapy.…”
    Get full text
    Article
  18. 7838

    A prospective hospital-based study on C-reactive protein as a response predictor of antidepressant treatment in drug naïve patients with major depressive disorder by Didakamiwan Khonglah, Arghya Pal, Nitu Mallik, Debes Ray, Malay Ghosal, Rudraprasad Acharya

    Published 2023-04-01
    “…Aims: This study was conducted to determine the relationship between the level of CRP to remission rates after antidepressant therapy. Methods: Fifty patients of first episode MDD with no past history of antidepressant exposure and other medical comorbidity were recruited after obtaining consent for Escitalopram therapy. …”
    Get full text
    Article
  19. 7839

    Congenital Hypothyroidism: An Unusual Combination of Biochemical Abnormalities by Ruchi Mantri, S. B. Bavdekar, Sushma U. Save

    Published 2016-01-01
    “…Following institution of oral thyroxin therapy, the serum bilirubin levels ameliorated (2.9 mg/dl) considerably by 15 days of therapy and the serum levels of AST (40 IU/dl) and ALT (20 IU/dl) got normalized. …”
    Get full text
    Article
  20. 7840

    Efficacy of Nivolumab in a Patient with Metastatic Renal Cell Carcinoma and End-Stage Renal Disease on Dialysis: Case Report and Literature Review by Jawaher Ansari, Muhammad Ali, Ashraf Farrag, Arwa M. Ali, Abdulaziz Alhamad

    Published 2018-01-01
    “…In addition, there is uncertainty regarding drug dosing/pharmacokinetics, lack of safety and efficacy data, and potential for increased toxicity when using targeted therapy or immunotherapy for the management of patients with mRCC on dialysis. …”
    Get full text
    Article